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In eukaryotes, a specialized pathway of mRNA
degradation termed nonsense-mediated decay
(NMD) functions in mRNA quality control by
recognizing and degrading mRNAs with aber-
rant termination codons. We demonstrate that
NMD in yeast targets premature termination
codon (PTC)-containing mRNA to P-bodies.
Upf1p is sufficient for targeting mRNAs to
P-bodies, whereas Upf2p and Upf3p act, at
least in part, downstream of P-body targeting
to trigger decapping. The ATPase activity of
Upf1p is required for NMD after the targeting
of mRNAs to P-bodies. Moreover, Upf1p can
target normal mRNAs to P-bodies but not pro-
mote their degradation. These observations
lead us to propose a new model for NMD
wherein two successive steps are used to dis-
tinguish normal and aberrant mRNAs.
INTRODUCTION
Eukaryotic cells contain quality-control mechanisms that
recognize and degrade aberrant mRNAs. One such qual-
ity-control system is referred to as nonsense-mediated
decay (NMD). NMD degrades a variety of substrates
with alterations in the normal spatial relationship between
the termination codon and other RNA features (Hilleren
and Parker, 1999; Baker and Parker, 2004; Maquat,
2004). The conserved core of the NMD machinery are
the Upf1, Upf2, and Upf3 proteins, which are required
for NMD in yeast, Drosophila, C. elegans, and mammalian
cells (Culbertson and Leeds, 2003; Maquat, 2004). To trig-
ger mRNA decay, NMD accelerates the rates of deadenyl-
ation, decapping, and in some cases endonucleolytic
cleavage (Stevens et al., 2002; Mitchell and Tollervey,
2003; Lejeune et al., 2003; Chen and Shyu, 2003; Takaha-
shi et al., 2003; Cao and Parker, 2003; Gatfield and Izaur-
ralde, 2004). In yeast, NMD primarily leads to deadenyla-
tion-independent decapping (Muhlrad and Parker, 1994;
Cao and Parker, 2003).Recent studies have identified cytoplasmic foci in both
yeast and mammals, referred to as P-bodies, that include
the decapping enzymes (Dcp1p/Dcp2p), activators of
decapping (Dhh1p, Pat1p, Lsm1-7p), and the 50 to 30 exo-
nuclease Xrn1p and generally lack translation factors (van
Dijk et al., 2002; Lykke-Andersen, 2002; Ingelfinger et al.,
2002; Sheth and Parker, 2003; Cougot et al., 2004). P-bod-
iesaredynamicstructuresand representpoolsofnontrans-
latingmRNPs (Sheth and Parker, 2003; Cougot et al., 2004;
Kshirsagar andParker, 2004; Ferraiuolo et al., 2005; Keder-
sha et al., 2005; Teixeira et al., 2005; Andrei et al., 2005).
P-bodies have roles inmRNA decapping and 50 to 30 decay
(Sheth and Parker, 2003; Cougot et al., 2004), in trans-
lational control (Coller and Parker, 2005), and in mRNA
storage (Brengues et al., 2005). These roles suggest that
cytoplasmic mRNAs shuttle in and out of P-bodies, and
that P-body size and number will be a function of the rates
of entry into P-bodies, decaywithin P-bodies, the aggrega-
tion rate of individual P-body mRNPs, and the rate of
mRNAs exiting the P-body structure. An important and
unresolved issue is whether the larger aggregates have
compositional and/or functional differences from the indi-
vidual mRNPs that are in the process of P-body assembly.
Three observations raise the possibility that NMDmight
involve targeting of PTC-containing mRNAs to P-bodies.
First, previous work has shown that recognition of an
mRNA as ‘‘nonsense containing’’ leads to its translational
repression (Muhlrad and Parker, 1999). Second, Dcp1p,
Dcp2p, and Xrn1p, which catalyze the degradative phase
of NMD, are concentrated in P-bodies (Sheth and Parker,
2003). Third, SMG5, SMG7, and UPF1, proteins involved
in NMD in higher eukaryotes, are localized to P-bodies in
mammalian cells under certain conditions (Unterholzner
and Izaurralde, 2004; Fukuhara et al., 2005).
Herein, we present evidence that NMD in yeast involves
formation of an mRNP that accumulates within P-bodies.
Moreover, we demonstrate that Upf1p is sufficient for tar-
geting mRNAs to P-bodies with Upf2p and Upf3p acting
later to trigger decapping of NMD substrates. Our results
suggest that Upf1p also targets normal mRNAs to P-bod-
ies and that normal and NMD substrates may be distin-
guished by a two-step sequential process, which would
be expected to increase the accuracy of the NMD selec-
tion process.Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc. 1095
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RESULTS
Upf1p, Upf2p, and Upf3p Can Localize to P-Bodies
Since Upf1p, Upf2p, and Upf3p are required for NMD, the
presence of these proteins in P-bodies would argue for the
occurrence of NMD in P-bodies. To address this issue,
a C-terminal GFP fusion of each Upf protein was con-
structed and the cellular localization of the chimeras
determined in wild-type cells. Northern analysis of the
CYH2 pre-mRNA, which is a substrate for NMD (He
et al., 1993), indicated that the tagged Upf1p, Upf2p,
andUpf3p are fully functional (data not shown). Consistent
with prior work (Atkin et al., 1995; Shirley et al., 1998),
GFP-tagged Upf1p, Upf2p, and Upf3p were uniformly dis-
tributed in the cytoplasm (Figure 1A, top panel). However,
if Upf proteins target mRNA to P-bodies but are released
rapidly after the degradation of the mRNA, they might
only accumulate in P-bodies if degradation of the mRNA
within P-bodies were blocked.
To test this model, we localized the Upf proteins in
strains blocked at the catalytic steps of decay. In
dcp1D, dcp2D, and xrn1D strains, Upf1p, Upf2p, and
Upf3p were present in cytoplasmic foci (Figure 1A, bottom
panel and data not shown), which in the dcp1D strain
colocalized with Dcp2p-RFP (Figure 1C). Quantification
of the images (see Experimental Procedures) indicated
an increase in both the number and area of Upf-GFP signal
within P-bodies (Figure 1B). These foci, and all other
microscopic data presented in this manuscript, unless
explicitly stated, were seen in greater than 80% of cells
examined. This observation suggests that theUpf proteins
cycle through P-bodies and accumulate in P-bodies when
decapping is blocked.
Since Dcp1p is involved in the decay of both normal and
nonsense-containing mRNAs (Beelman et al., 1996), the
accumulation of Upf proteins in P-bodies in a dcp1D strain
could be due to the accumulation of normal and/or non-
sense-containing mRNAs in these foci. To determine if
the accumulation of Upf proteins in P-bodies was specific
to NMD, we examined the distribution of Upf1p-GFP in a
lsm1D strain, which is only defective in the decapping of
only normalmRNAs (Boeck et al., 1998). In the lsm1D strain,
Upf1p-GFP is not concentrated in P-bodies (Figure 1D,
middle panel) as compared to a dcp1D strain (Figure 1A,bottom panel) or a dcp2D strain (Figures 1D, right panel,
and 1E). Similar results were also obtained for Upf2p-
GFP and Upf3p-GFP (data not shown). In contrast,
Dhh1p, an activator of decapping involved in the 50 to 30
decay of normal mRNA (Coller et al., 2001), accumulated
in P-bodies in lsm1D, dcp1D, and dcp2D strains (Figures
1F, middle panel and left panel and 1G and data not
shown). This result indicates that the presence of Upf pro-
teins in P-bodies is due to a defect in NMDand implies that
NMD targets PTC-containing mRNAs to P-bodies.
A Reporter mRNA Harboring a Nonsense Mutation
Localizes to P-Bodies
To directly test if NMD targets mRNAs to P-bodies, we ex-
amined the subcellular distribution of PGK1 mRNAs with
early (codon 22) or late (codon 225) nonsense codons.
We examined reporter mRNAs with early and late non-
sense codons since they differ in their rates of decapping,
have different rate-limiting steps in decay, and therefore
may respond differently in the NMD process (Cao and
Parker, 2003). These reporter mRNAs contained 16 U1A
binding sites in the 30 UTR of themRNA, which did not pre-
vent NMD (Figure S1), and a U1A-GFP fusion protein was
coexpressed, which allowed visualization of transcript lo-
calization (Bertrand et al., 1998; Brodsky and Silver, 2000;
Teixeira et al., 2005). When expressed by itself, the U1A-
GFP fusion protein showed no accumulation in P-bodies
(Figures 2A, top panel, and 2B). As compared to the
wild-type (wt) PGK1 mRNA, both the C22 and C225
mRNAs showed an increase in the number of P-bodies
and their overall area, as detected by the tethered U1A-
GFP (Figure 2A, right panel compare panel v (wt) to panel
ix (C22) and panel xiii (C225) and Figure 2B). Furthermore,
these mRNA-containing foci colocalized with RFP-tagged
Dcp2p (Figure S2). These results show that PTC-contain-
ing mRNAs accumulate in P-bodies.
To determine if the accumulation of the C22 and C225
mRNAs in P-bodies was due to NMD, we examined how
this localization was affected in upf1D, upf2D, and upf3D
strains. In upf1D strain, the accumulation of both the
C22 and C225 reporter mRNAs in P-bodies was reduced
both in the number of P-bodies observed and their overall
area (Figure 2A, x and xiv; Figures 2D and 2E). The contin-
ued accumulation of C22 mRNA in P-bodies in the upf1DFigure 1. Upf Proteins Are Localized to P-Bodies
(A) Localization of Upf1p-GFP (left), Upf2p-GFP (middle), and Upf3p-GFP (right) in wt strain (top) and in dcp1D strain (bottom).
(B) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Upf1p-GFP,
Upf2p-GFP, and Upf3p-GFP. * indicates p < 0.05 for wt versus dcp1D strain.
(C) Panel on the left (vertical) shows localization of GFP-tagged Upf proteins; middle panel (vertical) shows localization of RFP-tagged Dcp2p; and
panel on the right (vertical) shows the merge generated using Adobe Photoshop. Top row shows localization of Upf1p, middle panel shows the
localization of Upf2p, and bottom panel shows localization of Upf3p.
(D) shows localization of Upf1p-GFP in wt strain (left), lsm1D strain (middle), and dcp2D strain (right).
(E) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Upf1p-GFP.
* indicates p < 0.005 for wt versus dcp2D strain.
(F) Localization of Dhh1p-GFP in wt strain (left), lsm1D strain (middle), and dcp1D strain (right).
(G) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Dhh1p-GFP.
* indicates p < 0.05 for wt versus lsm1D and dcp1D strain.
Data are represented as mean of three experiments ± SD.Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc. 1097
Figure 2. Nonsense-Containing Full-Length Reporter mRNA Localizes to P-Bodies
(A) First panel from left to right: Plasmid expressing U1A-GFP alone in wt (i), upf1D (ii), upf2D (iii), and upf3D (iv) strains.
Second panel from left to right: Wild-type PGK1 reporter mRNA with U1A binding sites and plasmid expressing U1A-GFP in wt (v), upf1D (vi), upf2D
(vii), and upf3D (viii) strains.
Third panel from left to right: PGK1 mRNA with a premature stop codon at position 22 with U1A binding sites and plasmid expressing U1A-GFP in wt
(ix), upf1D (x), upf2D (xi), and upf3D (xii) strains.
Fourth panel from left to right: PGK1mRNAwith a premature stop codon at position 225with U1A binding sites and plasmid expressing U1AGFP in wt
(xiii), upf1D (xiv), upf2D (xv), and upf3D (xvi) strains.
All the mRNAs lack the pG tract to trap the decay intermediate. The schematic diagram of the reporter RNA and its interaction with the U1A-GFP
fusion protein is shown on the left.
(B) Cells containing no RNA, wt U1A RNA, C22 U1A RNA, and C225 U1A RNAmRNAs in a wt strain. * indicates p < 0.05 for wt U1AmRNA versus C22
and C225 U1A mRNAs.
(C) Cells containing wt U1A reporter mRNA in wt, upf1D, upf2D, and upf3D strains.
(D) Cells containing C22 U1A reporter mRNA in wt, upf1D, upf2D, and upf3D strains. a indicates p < 0.05 for wt strain versus upf1D strain, b indicates
p < 0.05 for wt strain versus upf2D and upf3D strains, and c indicates p < 0.0001 for upf1D versus upf2D and upf3D strains.
(E) Cells containing C225 U1A reporter mRNA in wt, upf1D, upf2D, and upf3D strains. * indicates p < 0.05 for wt strain versus upf1D, upf2D, and upf3D
strains.
Data are represented as mean of three experiments ± SD. Total of 50 cells were analyzed for this quantification.1098 Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc.
strain is likely to be due to the short ORF on this transcript,
and the inverse relationship seen between anmRNAbeing
associated with ribosomes or accumulating in P-bodies
(Brengues et al., 2005; Teixeira et al., 2005). It should be
noted that the decrease in P-body accumulation in the
upf1D strain was observed despite an increase in the
levels of the C22 and C225 mRNAs in the upf1D strain
due to an inhibition of NMD (Figure S1). This observation
argues that Upf1p is required for the targeting of NMD
substrates to P-bodies.
The C22 and C225 mRNAs behaved slightly differently
in upf2D and upf3D strains. TheC22mRNA showed an ap-
proximately 2-fold increase in P-bodies both in number
and area in upf2D and upf3D strains as compared to the
upf1D strain (Figures 2A, xi and xii, and 2D). The C225
mRNA also accumulated more detectable P-bodies in
upf2D and upf3D strains as compared to the upf1D strain,
although the overall area of these P-bodies was not signif-
icantly different (Figure 2A, xv and xvi, and 2E). These re-
sults suggest that Upf1p is the critical protein for targeting
mRNAs to P-bodies whereas Upf2p and Upf3p function,
at least in part, after P-body targeting of the mRNA (see
below). However, the reduction of the C225 mRNA in
P-bodies in upf2D and upf3D strains as compared to wt
strain suggests that Upf2p and Upf3p might also affect
the efficiency with which the C225 mRNA is targeted to
P-bodies (see Discussion).
Despite the differences in subcellular mRNA location, all
three Upf proteins are required for the rapid decay of the
C22 (early PTC) and C142 (intermediate PTC) transcripts
(Figure S3 and data not shown). This suggests that local-
ization of the PTC-containing mRNA to P-bodies by Upf1p
is not sufficient for its degradation and that Upf2p and
Upf3p are required to trigger decay of the mRNA.
Upf1p Acts upstream of Upf2p and Upf3p
The above observations suggest that a substep in NMD is
the targeting of the mRNA to a specific mRNP complex,
which can accumulate, and be detected, as P-bodies.
This accumulation of mRNAs and proteins in P-bodies
then becomes an assay for a substep in the NMDprocess.
Thus, we examined whether each Upf protein acts up-
stream or downstream of P-body formation by using
Dcp2p-GFP to monitor P-body formation in upf mutants.
Both the number and overall area of Dcp2p-GFP in P-bod-
ies increased in upf2D, upf3D, and upf2Dupf3D strains
(Figure 3A, compare i to iii, iv, vii, and viii). In contrast,
Dcp2p-GFP in the upf1D strain was distributed similarly
to the wild-type strain (Figure 3A, compare i and ii, and
viii). Moreover, GFP-tagged Dcp2p did not show in-
creased accumulation in P-bodies in the upf1Dupf2D or
upf1Dupf3D strain (Figure 3A, v, vi, and viii), indicating
that the accumulation of P-bodies in upf2D and up3D
strains is dependent on Upf1p. The changes in the P-bod-
ies are not due to differences in Dcp2p-GFP abundance
since the level of Dcp2p-GFP does not significantly differ
in these strains (Figure S4). These observations argue
that Upf1p functions upstream of Upf2p and Upf3p.To identify other proteins that accumulate in P-bodies in
upf2D and upf3D strains, we examined the localization of
Dcp1p-GFP, Xrn1-GFP, Dhh1p-GFP, Pat1p-GFP, and
Lsm1p-GFP in different upf mutants. As assessed by
both average P-body number and area, Dcp1p, Xrn1p,
Dhh1p, Pat1p, and Lsm1p accumulated in P-bodies in
upf2D and upf3D strains (Figure 3B, iii, iv, v, viii, ix, and x
and data not shown). This observation suggests two pos-
sibilities. First, normal mRNAs in the process of decay
might accumulate in P-bodies in upf2D and upf3D strains.
However, this possibility is unlikely since normal mRNAs
do not accumulate in P-bodies in upf2D and upf3D strains
(Figure 2C). More plausibly, when Upf1p targets an mRNA
to assemble a P-body complex it may recruit the decapp-
ing enzyme as part of a larger complex consisting of
the decapping enzymes (Dcp1p/Dcp2p), activators of
decapping (Dhh1p, Pat1p, and Lsm1-7p), and the 50 to
30 exonuclease Xrn1p.
Interdependence of Upf Proteins
Examining the location of each of the Upf proteins in
strains lacking one of the other two Upf proteins provided
three observations. First, Upf1p-GFP accumulated in
P-bodies in upf2D or upf3D and upf2Dupf3D strains (Fig-
ure 3C, ii, iii, and x and data not shown). This further
supports the model that Upf1p functions upstream, and
independently, of Upf2p and Upf3p. This result also im-
plies that Upf2p and Upf3p are required for degradation
of themRNA after P-body targeting. A second observation
was that Upf2p and Upf3p do not accumulate in P-bodies
in an upf1D strain (Figure 3C, v and viii) consistent with
Upf1p acting upstream of Upf2p and Upf3p. Third, in con-
trast to Upf1p, neither Upf2p nor Upf3p accumulated in
foci in upf3D or upf2D strains, respectively (Figure 3C, vi
and ix). This suggests that the stable accumulation of
Upf2p and Upf3p in P-bodies is interdependent.
These results argue that Upf1p is required for targeting
of PTC-containing mRNAs to P-bodies. In contrast, in
strains lacking Upf2p and Upf3p, mRNAs and associated
proteins accumulate in P-bodies, presumably due to the
action of Upf1p, but are not degraded. This is also sup-
ported by the observation that the localization of a reporter
mRNA harboring an early PTC to P-bodies is decreased in
upf1D, whereas its levels increase in upf2D and upf3D
strains (Figures 2A and 2D).
Upf1p Has a Central Role in Targeting mRNAs
to P-Bodies
Upf1p is a 50 to 30 ATP-dependent RNA helicase and its
ATPase activity is essential for NMD in an unknown man-
ner (Weng et al., 1996). One possibility is that the ATPase
activity of Upf1p may be required for the initial targeting of
mRNAs to P-bodies. This model predicts that a strain
expressing an ATPase-defective allele of Upf1p would
not be able to target mRNAs to P-bodies and therefore
P-bodies would decrease in size. Alternatively, the
ATPase domain could be required for degradation of the
mRNA substrate, after targeting to a P-body. In thisCell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc. 1099
Figure 3. Analysis of Upf Mutants
(A) Top panel (left to right): localization of Dcp2p-GFP in, wt (i), upf1D (ii), upf2D (iii), and upf3D (iv) strains.
Bottom panel (left to right): localization of Dcp2p-GFP in upf1Dupf2D (v), upf1Dupf3D (vi), and upf2Dupf3D (vii) strains.
(viii) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Dcp2p-GFP in
wt, upf1D, upf2D, upf3D, upf1Dupf2D, upf1Dupf3D, and upf2Dupf3D strains. a indicates p < 0.0005 for wt strain versus upf2D, upf3D, and upf2Dupf3D
strains (for wt strain versus upf1D, upf1D upf2D, and upf1Dupf3D strains the P values were high, indicating that they are very similar) and b indicates
p < 0.0005 for upf1D strain versus upf2D, upf3D, and upf2Dupf3D strains.
(B) Top panel (left to right): localization of Dhh1p-GFP in, wt (i), upf1D (ii), upf2D (iii), and upf3D (iv) strains.1100 Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc.
case, a strain expressing an ATPase-defective allele of
Upf1p would show an increase in P-bodies.
To test these predictions, we expressed wt Upf1p and
DE572AA, an ATPase-defective upf1 allele (Weng et al.,
1996) from a low-copy plasmid in an upf1D strain and
examined P-body number and area. We observed that
Dcp2p-GFP accumulated in P-bodies in cells expressing
the DE572AA upf1 allele (Figure 4A, iii and iv) but not in
strains containing either wt Upf1p or empty vector
(Figure 4A, i, ii, and iv). This suggests that the ATP hydro-
lysis activity of Upf1p is not required for P-body targeting
and instead may promote a rearrangement of the mRNP
within P-bodies that can trigger mRNA degradation.
Additional evidence for the role of the ATP hydrolysis
activity of Upf1p comes from overexpression of the
DE572AA upf1 allele from a two-micron plasmid in wild-
type strains expressing GFP-tagged Upf1p, Upf2p,
Upf3p, Dhh1p, Pat1p, or Lsm1p. GFP-tagged Upf1p,
Dhh1p, Pat1p, and Lsm1p localized to P-bodies in strains
overexpressing the DE572AA upf1 allele (Figures 4B, iii
and iv; 4C, iii, iv, vii, viii, xi and xii). Overexpressing wt
Upf1p, or presence of empty vector, had no effect on
the localization of all the proteins tested except for
Upf1p where overexpression of wt Upf1p led to a slight
increase in P-bodies (Figures 4B, i, ii and iv; 4C, i, ii, iv,
v, vi, viii, ix, x, and xii). Moreover, the accumulation of P-
bodies in strains overexpressing the DE572AA upf1 allele
is independent of Upf2p and Upf3p, as shown by the ac-
cumulation of Dcp2p-GFP in upf2D and upf3D strains
(Figure 4D, iii, iv, vii, and viii). In contrast to Upf1p, GFP-
tagged Upf2p and Upf3p did not localize to P-bodies in
strains overexpressing either wt Upf1p or the DE572AA
upf1 allele (Figure 4B, vi, vii, viii, x, xi, and xii). This obser-
vation indicates that either the DE572AA upf1 allele may
have lost its ability to recruit Upf2p or Upf3p or that
Upf2p and Upf3p may associate with the mRNP after
the ATP hydrolysis step.
Upf1p Can Target Normal mRNAs to P-Bodies
The accumulation of proteins in P-bodies in the DE572AA
allele of Upf1p argues that somemRNAs are accumulating
in P-bodies in this strain. Thus, we examined the localiza-
tion of both normal and nonsense mRNAs in an upf1D
strain expressing the DE572AA upf1 allele. The P-body
accumulation of the PTC (C22)-containing PGK1 reporter
mRNA slightly increased in the strain expressing the
DE572AA upf1 allele as compared to a strain expressingwt Upf1p (Figures 5A, bottom panel compare left to right,
and 5B, bottom panel). These results argue that ATP hy-
drolysis by Upf1p is not required for localization of non-
sense mRNAs, or associated proteins, to a P-body.
Surprisingly, the expression of the DE572AA upf1 allele
also led to clear accumulation of wt mRNAs in P-bodies as
assessed both by the number of P-bodies containing this
mRNA and their overall area (Figures 5A, top panel com-
pare left to right, and 5B, top panel). This observation
implies that Upf1p can also target normal mRNAs to
P-bodies and that they accumulate in P-bodies either be-
cause ATP hydrolysis is required for their degradation or
for their release back into translation. Transcriptional
pulse-chase experiments, which allow measurement of
the rates of both deadenylation and decapping of the
mRNA (Cao and Parker, 2003), indicated that deadenyla-
tion, decapping, and overall decay rates of the wt PGK1
mRNA were not affected by the DE572AA upf1 allele
(Figure 5C, i, ii, and iii). Moreover, we did not observe
even a small pool of mRNAs which might be stuck in a
nonproductive intermediate in the DE572AA allele and
thereby be responsible for the increased P-bodies. This
suggests that the ATP hydrolysis activity of Upf1p is
likely to be required to release a pool of normal mRNAs
that can be targeted to P-bodies by Upf1p back into the
translating pool.
The observation that Upf1p leads to the accumulation of
normal mRNAs in P-bodies suggests that Upf1p can re-
press the translation of normal mRNAs. This predicts
that overexpression of Upf1p might generally affect trans-
lation. To test this possibility, we overexpressed either wt
Upf1p or the DE572AA upf1 allele from the galactose pro-
moter in wild-type strain and examined P-body formation
and polysome profiles 2 hr after induction with galactose.
Compared to vector alone (Figure 6A), overexpression of
the DE572AA upf1 allele reduced polysomes (Figure 6C,
compare the red polysome trace [sucrose] to the gray [ga-
lactose] polysome trace) and showed a clear accumula-
tion of P-bodies (Figure 6C, compare ii to iii). In addition
to a reduction in polysomes and an increase in P-body
size, overexpression of the DE572AA upf1 allele also
inhibited growth (Figure 6C, compare iv to v) whereas
overexpression of wt Upf1 caused a minor, but clear,
decrease in growth rate (Figure 6B, compare iv to v).
These results are consistent with Upf1p repressing the
translation of a pool of ‘‘normal’’ mRNAs and targeting
those transcripts to P-bodies. Moreover, because the(v) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Dhh1p-GFP in wt,
upf1D, upf2D, and upf3D strains. * indicates p < 0.05 for wt strain versus upf2D and upf3D strains.
Bottom panel (left to right): localization of Pat1p-GFP in wt (vi), upf1D (vii), upf2D (viii), and upf3D (ix) strains.
(x) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Pat1p-GFP in wt,
upf1D, upf2D, and upf3D strains. * indicates p < 0.05 for wt strain versus upf2D and upf3D strains.
(C) Top panel: localization of Upf1p-GFP in wt (i), upf2D (ii), and upf3D (iii) strains.
Middle panel: localization of Upf2p-GFP in wt (iv), upf1D (v), and upf3D (vi) strains.
Bottom panel: Localization of Upf3p-GFP in wt (vii), upf1D (viii), and upf2D (ix) strains.
(x) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Upf1p-GFP in wt,
upf2D, and upf3D strains. * indicates p < 0.005 for wt strain versus upf2D and upf3D strains.
Data are represented as mean of three experiments ± SD.Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc. 1101
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DE572AA allele is more severe than overexpression of
the wt Upf1p, it implies that the DE572AA is inhibiting
the recycling of ‘‘normal’’ mRNAs back into translation
(see Discussion).
DISCUSSION
NMD Involves Targeting of PTC-Containing
Substrates to P-Bodies
Several observations indicate that the process of NMD in-
volves the assembly of anmRNP, which targets themRNA
for decapping and to P-bodies. First, Upf1p, Upf2p, and
Upf3p are localized to P-bodies when NMD is inhibited
at the nucleolytic steps in degradation (Figure 1). Second,
this accumulation of the Upf proteins in P-bodies is spe-
cific to the NMD pathway and does not occur when
decapping of normal mRNAs is inhibited (Figure 1). Third,
reporter mRNAs harboring PTCs are localized to P-bodies
in an Upf1p-dependent manner (Figure 2). Fourth, when
NMD is blocked in an upf2D or upf3D strain, or by an
ATPase-defective upf1 allele, P-bodies increase in num-
ber and area (Figures 3 and 4). These observations argue
that NMD in yeast occurs within complexes that can accu-
mulate into P-bodies. Moreover, because the basic princi-
ples of NMD are broadly conserved, and SMG5, SMG7,
and UPF1 proteins can accumulate in P-bodies in mam-
malian cells (Unterholzner and Izaurralde, 2004), it is antic-
ipated that NMD will occur within P-bodies in other eu-
karyotes, including mammals. An unresolved issue is
whether NMD requires assembly of aggregates into
a larger structure to occur, or if decapping can occur
within individual mRNPs that can eventually accumulate
within P-bodies.Upf1p Acts upstream of Upf2p and Upf3p to Promote
P-Body mRNP Formation
Multiple lines of evidence suggest that Upf1p acts first in
NMD and is required for targeting of PTC-containing
mRNAs to a P-body mRNP whereas Upf2p and Upf3p
act later. First, Upf1p-GFP and Dcp2p-GFP accumulate
in P-bodies in upf2D or upf3D strains (Figure 3). Moreover,
the accumulation of Dcp2p-GFP in P-bodies is dependent
on Upf1p since P-body number and area decrease in
upf1Dupf2D and upf1Dupf3D strains as compared to
upf2D or upf3D strains (Figure 3). Second, Upf2p and
Upf3p do not accumulate in P-bodies in an upf1D strain
(Figure 3). Third, overexpression of the DE572AA upf1 al-
lele causes accumulation of Dcp2p in P-bodies inde-
pendent of Upf2p or Upf3p (Figure 4). Moreover, reporter
mRNA localizations are also consistent with this model, as
mRNAs harboring both early as well as late nonsense co-
dons localize to P-bodies in an Upf1p-dependent manner
and independent of Upf2p and Upf3p (Figure 2). Indeed,
mRNAs with early nonsense codons also show a slight
increase in their accumulation in P-bodies in upf2D and
upf3D strains as compared to upf1D strain (Figure 2).
These observations argue that Upf1p acts first, and inde-
pendent of Upf2p and Upf3p, in formation of a P-body
mRNP, while Upf2p and Upf3p function, at least in part,
to subsequently trigger decapping and 50 to 30 decay of
NMD substrates. Note that because Upf1p and Dcp2p ac-
cumulate in P-bodies in upf2D and upf3D strains, yet the
mRNA is not subjected toNMD, these results imply that in-
teraction of the mRNA substrate with Upf1p and Dcp2p,
and its accumulation within P-bodies, is not sufficient to
trigger mRNA decay.
Since the efficient targeting of a reporter mRNA harbor-
ing a late PTC to P-bodies requires all three Upf proteinsFigure 4. Analysis of the DE572AA upf1 Allele
(A) upf1D strain transformedwith low-copy plasmid expressing empty vector (pRP415) (i), wt Upf1p (pRP910) (ii), DE572AA upf1 allele (pRP912) (iii). All
strains are transformed with plasmid containing Dcp2p-GFP as a marker for P-bodies.
(iv) Histogram represents average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for Dcp2p-GFP in
upf1D strain containing empty vector, wt Upf1p, or DE572AA upf1 allele. * indicates p < 0.005 for vector versus DE572AA upf1 allele.
(B) Localization of Upf1p-GFP (top), Upf2p-GFP (middle), Upf3p-GFP (bottom) in wt strain overexpressing empty vector (pRP415) (i, v, ix), or wt Upf1p
(pRP913) (ii, vi, x), or DE572AA upf1 allele (pRP915) (iii, vii, xi), respectively.
Histograms represent average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for:
(iv) Upf1-GFP strain containing empty vector, wt Upf1p, or DE572AA upf1 allele. * indicates p < 0.05 for vector versus wt Upf1p and DE572AA upf1
allele.
(viii) Upf2p-GFP strain containing vector, wt Upf1p, or DE572AA upf1 allele.
(xii) Upf3p-GFP strain containing vector, wt Upf1p, or DE572AA upf1 allele.
(C) Localization of Dhh1p-GFP (top), Pat1p-GFP (middle), Lsm1p-GFP (bottom) in wt strain overexpressing empty vector (i, v, ix), or wt Upf1p (ii, vi, x),
or DE572AA upf1 allele (iii, vii, xi).
Histograms represent average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for:
(iv) Dhh1p-GFP strain containing empty vector, wt Upf1p, or DE572AA upf1 allele. * indicates p < 0.0001 for vector versus DE572AA upf1 allele.
(viii) Pat1p-GFP strain containing empty vector, wt Upf1p, or DE572AA upf1 allele. * indicates p < 0.0001 for vector versus DE572AA upf1 allele.
(xii) Lsm1p-GFP strain containing empty vector, wt Upf1p, or DE572AA upf1 allele. * indicates p < 0.0001 for vector versus DE572AA upf1 allele.
(D) Localization of Dcp2p-GFP in upf1Dupf2D strain (top) or in upf1Dupf3D strain (bottom) overexpressing empty vector (i, v), or wt Upf1p (ii, vi), or
DE572AA upf1 allele (iii, vii).
Histograms represent average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for:
(iv) Dcp2p-GFP in upf1Dupf2D strain containing empty vector, wt Upf1p, or DE572AA upf1 allele. * indicates p < 0.005 for vector versus DE572AA upf1
allele.
(viii) Dcp2p-GFP in upf1Dupf3D strain containing empty vector, wt Upf1p, or DE572AA upf1 allele. * indicates p < 0.05 for vector versus DE572AA
upf1 allele.
Data are represented as mean of three experiments ± SD.Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc. 1103
Figure 5. ATPase Activity of Upf1p Is Not Required for Targeting of mRNAs to P-Bodies
(A) Localizing wt U1A RNA (top) or C22 U1A RNA (bottom) in upf1D strain transformed with low copy plasmid expressing wt Upflp (left panel) or
DE572AA upf1 allele (right panel).
(B) Histograms represent average number of P-bodies/cell (left Y axis) and average area of P-bodies/cell in pixels^2 (right Y axis) for:
Top panel: wt U1A RNA in upf1D strain expressing either wt Upflp or DE572AA upf1 allele. * indicates p < 0.05 for wt Upflp versus DE572AA upf1 allele.
Bottom panel: C22 U1A RNA in upf1D strain expressing either wt Upflp or DE572AA upf1 allele. * indicates p < 0.05 for wt Upflp versus DE572AA upf1
allele.
Data are represented as mean of three experiments ± SD. Total of 50 cells were analyzed for this quantification.
(C) (i) Transcriptional pulse-chase of wt PGK1 mRNA in upf1D strain expressing wt Upflp (left panel) or DE572AA upf1 allele (right panel). Plasmid
pRP469 was introduced into the strains by transformation and transcriptional pulse-chase performed as previously described (Decker and Parker,
1993).
(ii) shows the loading control using the oligo (oRP100) for the 7S RNA.
(iii) Graph showing the decay profile for wt PGK1 mRNA in upf1D strain expressing wt Upflp (blue) or DE572AA upf1 allele (pink).1104 Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc.
(Figure 2), it suggests that Upf2p and Upf3p may also in-
crease the efficiency of recognition of aberrant termination
events. However, some phenotypes of the upf2D and
upf3D strains could be due to the accumulation of Upf1p
in P-bodies, thereby limiting Upf1p. Consistent with this
possibility, it has been observed that some of the pheno-
types of the upf2D and upf3D strains are partially sup-
pressed by overexpression of Upf1p (Maderazo et al.,
2000). Thus, whether Upf2p and Upf3p also have a direct
role early in the NMD process remains to be clarified.
Another line of evidence for the role of Upf1 in the forma-
tion of the P-body complex comes from our studies of the
DE572AA upf1 allele. Strains expressing the DE572AA
upf1 allele accumulate P-body complexes, demonstrated
by the accumulation of Upf1p, Dcp2p, Dhh1p, Pat1p, and
Lsm1p (Figure 4). In addition, the expression of the
DE572AA upf1 allele leads to an increase in accumulation
of nonsense mRNAs in P-bodies (Figure 5). These obser-
vations imply that that the ATP hydrolysis function of
Upf1p is not required for the initial recognition and target-
ing of mRNAs to P-bodies.
Recent results suggest that Upf1p also acts upstream
and independently of Upf2p and Upf3p in mammalian
cells. The key observation is that siRNA knockdown of
Upf2p or Upf3p leads to the accumulation of a ‘‘SURF’’
complex consisting of eRF1, eRF3, Upf1, and SMG-1, a ki-
nase that acts on Upf1 (Kashima et al., 2006). This obser-
vation, the direct effect of Upf1p on termination in vitro
(Amrani et al., 2004), and Upf1p’s ability to target mRNAs
to P-bodies in yeast argue that Upf1p acts first during
recognition of aberrant translation termination events,
independent of Upf2p and Upf3p. Upf1p may also have
a second functional role, after ATP hydrolysis and its inter-
action with Upf2p and Upf3p, in triggering the actual
decay of the PTC-containing transcript.
Upf1p Can Target Normal mRNAs to P-Bodies
Several lines of evidence argue that Upf1p can also target
normal mRNAs to P-bodies. First, and most importantly,
strains containing the DE572AA upf1 allele show an accu-
mulation of the normal PGK1 mRNAs in P-bodies (Fig-
ure 5). Second, overexpression of the DE572AA upf1 allele
leads to a small, but reproducible, reduction in polysomes
and an increase in P-body size (Figure 6). Third, overex-
pression of DE572AA upf1 allele also inhibits growth,
even in the absence of Upf2p and Upf3p (Figure 6 and
data not shown). Because overexpression of wt Upf1p
also has a minor and reproducible effect on growth rate
and accumulation of P-bodies, the translational repres-
sion of normal mRNA is not unique to the DE572AA upf1
allele. Consistent with that view, several other ATPase
defective alleles of Upf1p also lead to accumulation of
P-bodies (Muhlrad and Parker, unpublished observation).
This suggests that the stronger defect in the DE572AA
upf1 allele is due to the ATPase mutant trapping mRNAs
in P-bodies that would otherwise normally return to trans-
lation. Interestingly, Upf1p can affect the rate of decapp-
ing of normal mRNAs in xrn1D strains, indicating thatunder some conditions targeting of normal mRNAs to
P-bodies might affect their decay rate (He and Jacobson,
2001). These observations suggest that Upf1p can target
at least a subset of normal mRNAs to P-bodies. More im-
portantly, these observations imply that NMD in yeast may
require at least two phases of substrate distinction, one
outside of P-bodies during translation termination event
and another within the P-body following ATP hydrolysis.
A Model for the Process of Nonsense-Mediated
Decay
The above experiments can be incorporated into an
emerging model for NMD with the following features (Fig-
ure 7). First, there are two kinds of translation termination
events: normal and aberrant, with aberrant terminations
leading to the recruitment of Upf1p to the termination
complex. The presence of Upf1p in the termination com-
plex promotes the mRNA to stop translation and recruits
Dcp1p, Dcp2p, Dhh1p, Pat1p, and Lsm1p-7p, thereby
forming an mRNP capable of aggregation into a larger
P-body. Because Pab1p is thought to compete with
Upf1 for access to the termination complex (Amrani
et al., 2004), this initial discrimination between normal
and aberrant termination, on both normal and PTC-
containing mRNAs, may simply be a result of competition
between Pab1p and Upf1p for access to the termination
complex. This suggests that, following deadenylation,
a subset of normal mRNAs could be targeted to P-bodies
by Upf1p. However, since most normal mRNAs are not
affected by Upf1p, and decay rates of the normal PGK1
mRNA after deadenylation are not affected by Upf1p
(Cao and Parker, 2003), this targeting of normal
mRNAs to P-bodies does not generally appear to trigger
their degradation, perhaps due to the absence of Upf2p
and Upf3p.
In a downstream step, Upf1p must hydrolyze ATP and
recruit Upf2p and Upf3p to trigger mRNA degradation. In
yeast, ATP hydrolysis appears to be required for Upf2p/
Upf3p recruitment since in the DE572AA allele the non-
sense mRNA and associated proteins accumulate in
P-bodies but Upf2p and Upf3p do not (Figure 5). Whether
there is an obligate order to ATP hydrolysis by Upf1p and
its interaction with Upf2p/Upf3p is unclear since in mam-
malian cells, ATPase-defective alleles of Upf1p show
increased coimmunoprecipitation with Upf2p and Upf3p,
suggesting that Upf1p interaction with Upf2p and Upf3p
can be independent of ATP hydrolysis (Kashima et al.,
2006). Following ATP hydrolysis by Upf1p within the
P-body mRNP, we hypothesize that normal mRNAs are
unable to recruit Upf2p or Upf3p and therefore reinitiate
translation. In contrast, PTC-containing mRNAs efficiently
recruit Upf2p and Upf3p, allowing a second discrimination
between normal and nonsense mRNAs and thereby
increasing the fidelity of NMD. The interaction of Upf1p
with Upf2p and Upf3p on the nonsense mRNAs leads to
decapping and 50 to 30 degradation of the mRNA within
the P-body. In mammalian cells and C. elegans, Upf2p
and Upf3p may activate decay in part by phosphorylationCell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc. 1105
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Figure 7. A Model for the Process of Nonsense-Mediated Decayof Upf1p (Page et al., 1999; Kashima et al., 2006). How-
ever, since phosphorylation of Upf1p is not known to be
required for NMD in yeast, Upf2p and Upf3p might also
activate decapping by other means.
An important issue is how Upf2p and Upf3p interact dif-
ferently with normal and aberrant mRNAs. In yeast,
mRNAs with PTCs might recruit Upf2p and Upf3p effec-
tively due to their interactions with RNA binding proteins,
such as Hrp1p, still bound to the coding region of the
mRNA (Gonzalez et al., 2000). OnmRNAs with a complete
open reading frame, such proteins could have been dis-
lodged by elongating ribosomes. In mammalian cells,
a reasonable model is that the exon-junction complex,
which is deposited by splicing, contains Upf2p and
Upf3p and functions in the discrimination of normal and
aberrant mRNAs in mammals (Maquat, 2004) and effec-
tively delivers Upf2p and Upf3p to Upf1p. This provides
a possible explanation for observations that NMD inmam-
malian cells can function, albeit less efficiently, indepen-
dent of an EJC (Exon Junction Complex) (Zhang et al.,
1998; Buhler et al., 2006). This suggests that the EJCmay only affect NMD when Upf1p interaction with Upf2p
and Upf3p is the limiting step in the process, thereby
providing a possible explanation for why the EJC is only
required for NMD in mammalian cells.
EXPERIMENTAL PROCEDURES
Yeast Strains
See Table S1.
Preparing Cells for Confocal Microscopy
The cells were grown to an O.D600 of 0.3 at 30ºC in YEP or synthetic
medium containing 2% dextrose as a carbon source, washed two
times with complete minimal medium containing 2% dextrose, resus-
pended in the same medium used for washing, and rapidly observed.
Observations were made using a Nikon PCM 2000 Confocal Micro-
scope using a 1003 objective with 23 or 33 zoom using Compix Soft-
ware. All images are a compilation of 8–12 images in a stack.
Colocalization Experiments
GFP-tagged strains were transformed with a TRP1 cen plasmid con-
taining Dcp2p-RFP (pRP1156). The transformants were grown to anFigure 6. Overexpression of DE572AA upf1 Allele Causes Translational Repression, an Increase in P-Bodies, and Inhibition of
Growth
Polysome profiles (i, sucrose in red and galactose in gray), P-body accumulation (ii and iii), and growth assays (iv and v) in wt strain expressing empty
vector (A), or overexpressing wt Upf1p (B), or overexpressing DE572AA upf1 allele (C). All the polysome profiles were obtained using UV monitor
Uvicord SII, Pharmacia at 254 nm wavelength and 0.5AUFS sensitivity. P-bodies were visualized using Dcp2p-GFP.Cell 125, 1095–1109, June 16, 2006 ª2006 Elsevier Inc. 1107
O.D600 of 0.3 in synthetic media containing 2% dextrose lacking tryp-
tophan. The cells were collected and observed as described above.
Method for Visualizing the Full-Length Reporter mRNA
Wild-type yeast cells were transformed with plasmid pRP1187 (ex-
pressing the U1A-GFP fusion protein), and either plasmid pPS 2037
(centromeric plasmid expressing the wt PGK1mRNAwith U1A binding
sites), or plasmid pRP1295 (centromeric plasmid expressing PGK1
mRNA harboring an early nonsense mutation at position 22 and U1A
binding sites), or plasmid pRP1296 (centromeric plasmid expressing
the PGK1mRNAwith a nonsense codon at position 225 and U1A bind-
ing sites). The cells were grown, collected, and observed as described
above. For colocalization, the same cells were transformed with plas-
mid pRP1156 (expressing Dcp2p-RFP on a cen plasmid with the TRP
marker).
RNA Analysis
Transcriptional pulse-chases were done as described earlier (Decker
and Parker, 1993).
Polysome Analysis
Analysis was performed as described in Coller and Parker (2005). Cells
were grown in selective media containing 2% sucrose, harvested, and
split into two cultures. They were resuspended in media containing ei-
ther 2% Sucrose or 0.25% Sucrose and 2% Galactose. Cultures were
incubated for 120 min and then harvested. The polysomes were ana-
lyzed using 15%–50% sucrose gradients.
P-Body Quantification
Randomly selected images from each experiment were analyzed using
Image J (Abramoff et al., 2004). After image smoothing and back-
ground cellular fluorescence subtraction (established independently
for each protein), automatic image thresholding was performed using
the Otsu thresholding plugin (Otsu, 1979). The number and area of
P-bodies was determined by using the ‘‘Analyze particles’’ function
in Image J. Minimum pixel size and maximum pixel sizes were set
and average number and area of P-bodies per cell were obtained. It
should be noted that because of threshold subtractions, such quanti-
fications are not necessarily absolute numbers or areas of P-bodies
but provide a systematic and unbiased measure of relative P-body
number and area within experiments. Total of 75 cells were analyzed
for this quantification analysis unless otherwise indicated. P values
were calculated using Two-tailed Student’s t test for both the number
and area of P-bodies.
Supplemental Data
Supplemental Data include four figures and one table and can be
found with this article online at http://www.cell.com/cgi/content/full/
125/6/1095/DC1/.
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